MCAM and systemic sclerosis: In systemic sclerosis patients show high levels of different isoforms of soluble CD146 (scCD146), which are responsible for profibrotic effects through dysregulation of the Wnt-1/ β-catenin pathway and proangiogenic activity via up-regulation of the PKCε pathway [36].